Found 37 matching trials
Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection PHASE2 This phase II trial studies how well donor cytomegalovirus-specific cytotox...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
CMV CTLs in Neonates With CMV Infection PHASE2 Patients with moderate or severe CMV disease less than 21 days old who have...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant NA RATIONALE: Tests that measure certain changes in blood in patients at high ...
Show More Location
Multiple Locations
Learn More & Join Trial
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma PHASE1 This phase I/II trial studies the side effects and best dose of autologous ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
CMV-CTL for the Treatment of CMV Infection After HSCT PHASE4 Human cytomegalovirus (CMV) infection is a major cause of morbidity and mor...
Show More Location
Shanghai Jiao Tong University Affilated Shanghai General Hospital
Learn More & Join Trial
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant PHASE2 This is a Phase 3 study to evaluate posoleucel (ALVR105, Viralym-M); an all...
Show More Location
University of Alabama at Birmingham Children's of Alabama
Learn More & Join Trial
Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation PHASE2 The goal of this clinical research study is to learn if giving cytotoxic T ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT PHASE1 Human cytomegalovirus (CMV) is a benign infectious agent in the normal host...
Show More Location
Duke University Medical Center
Learn More & Join Trial